Literature DB >> 11395157

St John's wort: Prozac from the plant kingdom.

G Di Carlo1, F Borrelli, E Ernst, A A Izzo.   

Abstract

Conventional antidepressants are associated with a range of adverse drug reactions. The herb Hypericum perforatum (St John's wort) might offer another approach to the treatment of depression. Biochemical and animal studies suggest that the phloroglucinol derivative hyperforin is the main active ingredient of St John's wort, and inhibits the synaptosomal uptake of 5-HT, noradrenaline, dopamine, glutamate and GABA. St John's wort has been shown to alleviate symptoms of mild to moderate depression, and seems to offer significant advantages over conventional antidepressants because it is associated with fewer adverse reactions. However, important herb--drug interactions have been described. In view of its efficacy and safety records, St John's wort should be considered for the first-line treatment of mild to moderate depression.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11395157     DOI: 10.1016/s0165-6147(00)01716-8

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  33 in total

1.  Autoradiographic quantification of neurochemical markers of serotonin, dopamine and opioid systems in rat brain mesolimbic regions following chronic St John's wort treatment.

Authors:  Feng Chen; Amir H Rezvani; Andrew J Lawrence
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-01-23       Impact factor: 3.000

2.  Safety implications regarding use of phytomedicines.

Authors:  Laura Cuzzolin; Silvana Zaffani; Giuseppina Benoni
Journal:  Eur J Clin Pharmacol       Date:  2005-12-03       Impact factor: 2.953

3.  Inhibitory effect of the herbal antidepressant St. John's wort (Hypericum perforatum) on rat gastric motility.

Authors:  Raffaele Capasso; Francesca Borrelli; Gabriella Aviello; Francesco Capasso; Angelo A Izzo
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-01-03       Impact factor: 3.000

4.  Hyperforin activates nonselective cation channels (NSCCs).

Authors:  Kristina Treiber; Andrea Singer; Bettina Henke; Walter E Müller
Journal:  Br J Pharmacol       Date:  2005-05       Impact factor: 8.739

5.  Reversal of Calcium Dysregulation as Potential Approach for Treating Alzheimer's Disease.

Authors:  Elena Popugaeva; Daria Chernyuk; Ilya Bezprozvanny
Journal:  Curr Alzheimer Res       Date:  2020       Impact factor: 3.498

6.  Neuroprotective effect of H. perforatum extracts on beta-amyloid-induced neurotoxicity.

Authors:  Bruno A Silva; Alberto C P Dias; Federico Ferreres; João O Malva; Catarina R Oliveira
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

Review 7.  Hypericins as potential leads for new therapeutics.

Authors:  Anastasia Karioti; Anna Rita Bilia
Journal:  Int J Mol Sci       Date:  2010-02-04       Impact factor: 5.923

8.  Effect of St. John's Wort (Hypericum perforatum) treatment on restraint stress-induced behavioral and biochemical alteration in mice.

Authors:  Anil Kumar; Ruchika Garg; Atish K Prakash
Journal:  BMC Complement Altern Med       Date:  2010-05-07       Impact factor: 3.659

9.  Tetrahydrohyperforin and octahydrohyperforin are two new potent inhibitors of angiogenesis.

Authors:  Beatriz Martínez-Poveda; Luisella Verotta; Ezio Bombardelli; Ana R Quesada; Miguel Angel Medina
Journal:  PLoS One       Date:  2010-03-09       Impact factor: 3.240

Review 10.  Interactions between herbal medicines and prescribed drugs: an updated systematic review.

Authors:  Angelo A Izzo; Edzard Ernst
Journal:  Drugs       Date:  2009       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.